| Schedule of derivative liabilities |
| Schedule of derivative liabilities | |
| | | |
| | |
| | |
March 31, 2022 | |
| The financings giving rise to derivative financial instruments | |
Indexed Shares | | |
Fair Values | |
| Compound embedded derivatives | |
| 3,418,910,016 | | |
$ | (3,831,191 | ) |
| Total | |
| 3,418,910,016 | | |
$ | (3,831,191 | ) |
The following tables summarize the components
of the Company’s derivative liabilities and linked common shares as of March 31, 2021:
| | |
March 31, 2021 | |
| The financings giving rise to derivative financial instruments | |
Indexed Shares | | |
Fair Values | |
| Compound embedded derivatives | |
| 347,942,680 | | |
$ | (1,137,623 | ) |
| Total | |
| 347,942,680 | | |
$ | (1,137,623 | ) |
The following table summarizes the effects on
the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing
for the years ended March 31, 2022 and 2021:
| | |
March 31, | | |
March 31, | |
| | |
2022 | | |
2021 | |
| | |
| | |
| |
| Compound embedded derivatives | |
$ | (1,181,178 | ) | |
$ | (1,332,661 | ) |
| Day one derivative loss | |
| (45,485 | ) | |
| (151,978 | ) |
| Total | |
$ | (1,226,663 | ) | |
$ | (1,484,639 | ) |
|
| Schedule of changes in fair value of derivatives |
| Schedule of changes in fair value of derivatives | |
| | | |
| | |
| | |
March 31, | | |
March 31, | |
| | |
2022 | | |
2021 | |
| | |
| | |
| |
| Beginning balance | |
$ | 1,137,623 | | |
$ | 58,790 | |
| Issuances: | |
| | | |
| | |
| Compound embedded derivatives | |
| 2,038,843 | | |
| 732,416 | |
| Conversions | |
| (328,638 | ) | |
| (859,352 | ) |
| Derivative extinguished / debt repaid in cash | |
| (243,300 | ) | |
| (126,892 | ) |
| Loss (gain) on changes in fair value inputs and assumptions reflected in income | |
| 1,181,178 | | |
| 1,332,661 | |
| Day one derivative expense | |
| 45,485 | | |
| – | |
| Total | |
$ | 3,831,191 | | |
$ | 1,137,623 | |
|